Modeling the Combination of Amphotericin B, Micafungin, and Nikkomycin Z against Aspergillus fumigatus In Vitro Using a Novel Response Surface Paradigm

Antimicrobial Agents and Chemotherapy
2007.0

Abstract

Response surface methods for the study of multiple-agent interaction allow one to model all of the information present in full concentration-effect data sets and to visualize and quantify local regions of synergy, additivity, and antagonism. In randomized wells of 96-well plates, Aspergillus fumigatus was exposed to various combinations of amphotericin B, micafungin, and nikkomycin Z. The experimental design was comprised of 91 different fixed-ratio mixtures, all performed in quintuplicate. After 24 h of drug exposure, drug effect on fungal viability was assessed using the tetrazolium salt 2,3-bis {2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide} (XTT) assay. First, we modeled each fixed-ratio combination alone using the four-parameter Hill concentration-effect model. Then, we modeled each parameter, including the 50% inhibitory concentration (IC(50)) effect, versus the proportion of each agent using constrained polynomials. Finally, we modeled the three-agent response surface overall. The overall four-dimensional response surface was complex, but it can be explained in detail both analytically and graphically. The grand model that fit the best included complex polynomial equations for the slope parameter m and the combination index (equivalent to the IC(50) for a fixed-ratio concentration, but with concentrations normalized by the respective IC(50)s of the drugs alone). There was a large region of synergy, mostly at the nikkomycin Z/micafungin edge of the ternary plots for equal normalized proportions of each drug and extending into the center of the plots. Applying this response surface method to a huge data set for a three-antifungal-agent combination is novel. This new paradigm has the potential to significantly advance the field of combination antifungal pharmacology.

Knowledge Graph

Similar Paper

Modeling the Combination of Amphotericin B, Micafungin, and Nikkomycin Z against Aspergillus fumigatus In Vitro Using a Novel Response Surface Paradigm
Antimicrobial Agents and Chemotherapy 2007.0
Concentration-Dependent Synergy and Antagonism within a Triple Antifungal Drug Combination againstAspergillusSpecies: Analysis by a New Response Surface Model
Antimicrobial Agents and Chemotherapy 2007.0
Caspofungin in Combination with Amphotericin B against Candida parapsilosis
Antimicrobial Agents and Chemotherapy 2007.0
Isobolographic Analysis of Pharmacodynamic Interactions between Antifungal Agents and Ciprofloxacin against Candida albicans and Aspergillus fumigatus
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Interactions between Tacrolimus and Azoles against Candida albicans Determined by Different Methods
Antimicrobial Agents and Chemotherapy 2008.0
Synergistic Activities of Azithromycin and Amphotericin B against Naegleria fowleri In Vitro and in a Mouse Model of Primary Amebic Meningoencephalitis
Antimicrobial Agents and Chemotherapy 2007.0
In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes
Antimicrobial Agents and Chemotherapy 2009.0
Interactions between Triazoles and Amphotericin B in Treatment of Disseminated Murine Infection by Fusarium oxysporum
Antimicrobial Agents and Chemotherapy 2009.0
Posaconazole Enhances the Activity of Amphotericin B against Hyphae of Zygomycetes In Vitro
Antimicrobial Agents and Chemotherapy 2008.0
Combined Therapies in a Murine Model of Blastoschizomycosis
Antimicrobial Agents and Chemotherapy 2007.0